Traditional classification methods often fall short in capturing the complexity of cancer. Molecular classification provides deeper insights into the biological mechanisms driving cancer, which can lead to the identification of specific biomarkers and therapeutic targets. This has significant implications for improving treatment outcomes and reducing side effects.
